"sample_name"	"unique_patient_ID"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"Dstage"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"disease_specific_mortality"	"batch"	"drug_name"	"drug_treatment"	"drug_response"	"preop_drug_treatment"	"preop_drug_name"	"fu"	"bevacizumab"	"irinotecan"	"cetuximab"	"capecitabine"	"dexamethasone"	"gcsf"	"fudr"	"folfiri"	"folfox"	"leucovorin"	"mitomycin"	"platin"	"panitumumab"	"pegfilgrastim"	"raltitrexed"	"ancillary"	"chemotherapy"	"moltherapy"	"uncurated_author_metadata"
"GSM662633"	NA	"COL2_011853"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"64"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_011853///geo_accession: GSM662633///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 64///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662633/GSM662633.CEL.gz///data_row_count: 54675"
"GSM662634"	NA	"COL2_030625"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"76"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_030625///geo_accession: GSM662634///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 76///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1114///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662634/GSM662634.CEL.gz///data_row_count: 54675"
"GSM662635"	NA	"COL2_031424"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"94"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_031424///geo_accession: GSM662635///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 94///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662635/GSM662635.CEL.gz///data_row_count: 54675"
"GSM662636"	NA	"COL2_10228"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"65"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_10228///geo_accession: GSM662636///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 65///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 1386///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662636/GSM662636.CEL.gz///data_row_count: 54675"
"GSM662637"	NA	"COL2_10411"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"81"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_10411///geo_accession: GSM662637///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 81///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 516///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662637/GSM662637.CEL.gz///data_row_count: 54675"
"GSM662638"	NA	"COL2_10602"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"78"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_10602///geo_accession: GSM662638///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 78///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 213///characteristics_ch1.6: second apc mutation: 1489///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662638/GSM662638.CEL.gz///data_row_count: 54675"
"GSM662639"	NA	"COL2_10937"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"83"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_10937///geo_accession: GSM662639///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 83///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 1556///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662639/GSM662639.CEL.gz///data_row_count: 54675"
"GSM662640"	NA	"COL2_11060"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"56"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_11060///geo_accession: GSM662640///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 56///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 499///characteristics_ch1.6: second apc mutation: 1378///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662640/GSM662640.CEL.gz///data_row_count: 54675"
"GSM662641"	NA	"COL2_11196"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"58"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_11196///geo_accession: GSM662641///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 58///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1506///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662641/GSM662641.CEL.gz///data_row_count: 54675"
"GSM662642"	NA	"COL2_112"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"75"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_112///geo_accession: GSM662642///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 75///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 499///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662642/GSM662642.CEL.gz///data_row_count: 54675"
"GSM662643"	NA	"COL2_11538"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"71"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_11538///geo_accession: GSM662643///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 71///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662643/GSM662643.CEL.gz///data_row_count: 54675"
"GSM662644"	NA	"COL2_12"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"66"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_12///geo_accession: GSM662644///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 66///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1328///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662644/GSM662644.CEL.gz///data_row_count: 54675"
"GSM662645"	NA	"COL2_14604"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"34"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_14604///geo_accession: GSM662645///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 34///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 1368///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662645/GSM662645.CEL.gz///data_row_count: 54675"
"GSM662646"	NA	"COL2_174"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_174///geo_accession: GSM662646///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1310///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662646/GSM662646.CEL.gz///data_row_count: 54675"
"GSM662647"	NA	"COL2_187"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"77"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_187///geo_accession: GSM662647///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 77///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 621///characteristics_ch1.6: second apc mutation: 1407///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662647/GSM662647.CEL.gz///data_row_count: 54675"
"GSM662648"	NA	"COL2_197"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_197///geo_accession: GSM662648///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1318///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662648/GSM662648.CEL.gz///data_row_count: 54675"
"GSM662649"	NA	"COL2_200"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-18"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_200///geo_accession: GSM662649///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1309///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662649/GSM662649.CEL.gz///data_row_count: 54675"
"GSM662650"	NA	"COL2_206"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"71"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-11"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_206///geo_accession: GSM662650///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 71///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 631///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662650/GSM662650.CEL.gz///data_row_count: 54675"
"GSM662651"	NA	"COL2_208"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"78"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-11"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_208///geo_accession: GSM662651///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 78///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1495///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662651/GSM662651.CEL.gz///data_row_count: 54675"
"GSM662652"	NA	"COL2_21"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"64"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_21///geo_accession: GSM662652///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 64///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662652/GSM662652.CEL.gz///data_row_count: 54675"
"GSM662653"	NA	"COL2_211"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-11"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_211///geo_accession: GSM662653///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662653/GSM662653.CEL.gz///data_row_count: 54675"
"GSM662654"	NA	"COL2_225"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"55"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-05"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_225///geo_accession: GSM662654///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 55///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662654/GSM662654.CEL.gz///data_row_count: 54675"
"GSM662655"	NA	"COL2_241"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"77"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-05"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_241///geo_accession: GSM662655///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 77///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662655/GSM662655.CEL.gz///data_row_count: 54675"
"GSM662656"	NA	"COL2_244"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"72"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_244///geo_accession: GSM662656///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 72///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LUNG///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662656/GSM662656.CEL.gz///data_row_count: 54675"
"GSM662657"	NA	"COL2_26"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"49"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_26///geo_accession: GSM662657///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 49///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1319///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662657/GSM662657.CEL.gz///data_row_count: 54675"
"GSM662658"	NA	"COL2_284"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"84"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-05"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_284///geo_accession: GSM662658///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 84///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 213///characteristics_ch1.6: second apc mutation: 1488///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662658/GSM662658.CEL.gz///data_row_count: 54675"
"GSM662659"	NA	"COL2_315"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"71"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-11"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_315///geo_accession: GSM662659///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 71///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662659/GSM662659.CEL.gz///data_row_count: 54675"
"GSM662660"	NA	"COL2_363"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"46"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_363///geo_accession: GSM662660///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 46///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1355///characteristics_ch1.6: second apc mutation: 1399///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662660/GSM662660.CEL.gz///data_row_count: 54675"
"GSM662661"	NA	"COL2_386"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"72"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_386///geo_accession: GSM662661///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 72///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 1488///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662661/GSM662661.CEL.gz///data_row_count: 54675"
"GSM662662"	NA	"COL2_426"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"71"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-05"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_426///geo_accession: GSM662662///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 71///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1114///characteristics_ch1.6: second apc mutation: 1415///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662662/GSM662662.CEL.gz///data_row_count: 54675"
"GSM662663"	NA	"COL2_44"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"73"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_44///geo_accession: GSM662663///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 73///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1127///characteristics_ch1.6: second apc mutation: 1474///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662663/GSM662663.CEL.gz///data_row_count: 54675"
"GSM662664"	NA	"COL2_510"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"88"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_510///geo_accession: GSM662664///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 88///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662664/GSM662664.CEL.gz///data_row_count: 54675"
"GSM662665"	NA	"COL2_512"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"60"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_512///geo_accession: GSM662665///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 60///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1309///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662665/GSM662665.CEL.gz///data_row_count: 54675"
"GSM662666"	NA	"COL2_519"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"61"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_519///geo_accession: GSM662666///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 61///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1406///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662666/GSM662666.CEL.gz///data_row_count: 54675"
"GSM662667"	NA	"COL2_533"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"79"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_533///geo_accession: GSM662667///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 79///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1309///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662667/GSM662667.CEL.gz///data_row_count: 54675"
"GSM662668"	NA	"COL2_534"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"53"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_534///geo_accession: GSM662668///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 53///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1114///characteristics_ch1.6: second apc mutation: 1286///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662668/GSM662668.CEL.gz///data_row_count: 54675"
"GSM662669"	NA	"COL2_538"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"49"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-11"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_538///geo_accession: GSM662669///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 49///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 438///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662669/GSM662669.CEL.gz///data_row_count: 54675"
"GSM662670"	NA	"COL2_625"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"75"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-13"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_625///geo_accession: GSM662670///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 75///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 499///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662670/GSM662670.CEL.gz///data_row_count: 54675"
"GSM662671"	NA	"COL2_684"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"86"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2007-12-14"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_684///geo_accession: GSM662671///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 86///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662671/GSM662671.CEL.gz///data_row_count: 54675"
"GSM662672"	NA	"COL2_701"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"31"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_701///geo_accession: GSM662672///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 31///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1114///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662672/GSM662672.CEL.gz///data_row_count: 54675"
"GSM662673"	NA	"COL2_702"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"78"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_702///geo_accession: GSM662673///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 78///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662673/GSM662673.CEL.gz///data_row_count: 54675"
"GSM662674"	NA	"COL2_704"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"75"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_704///geo_accession: GSM662674///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 75///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662674/GSM662674.CEL.gz///data_row_count: 54675"
"GSM662675"	NA	"COL2_705"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"76"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_705///geo_accession: GSM662675///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 76///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: deletion///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662675/GSM662675.CEL.gz///data_row_count: 54675"
"GSM662676"	NA	"COL2_706"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"66"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_706///geo_accession: GSM662676///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 66///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662676/GSM662676.CEL.gz///data_row_count: 54675"
"GSM662677"	NA	"COL2_707"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"78"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_707///geo_accession: GSM662677///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 78///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1211///characteristics_ch1.6: second apc mutation: 1309///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662677/GSM662677.CEL.gz///data_row_count: 54675"
"GSM662678"	NA	"COL2_708"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"43"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_708///geo_accession: GSM662678///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 43///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662678/GSM662678.CEL.gz///data_row_count: 54675"
"GSM662679"	NA	"COL2_709"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"54"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_709///geo_accession: GSM662679///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 54///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1059///characteristics_ch1.6: second apc mutation: 1291///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662679/GSM662679.CEL.gz///data_row_count: 54675"
"GSM662680"	NA	"COL2_7094"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"87"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_7094///geo_accession: GSM662680///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 87///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1309///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662680/GSM662680.CEL.gz///data_row_count: 54675"
"GSM662681"	NA	"COL2_711"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"71"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_711///geo_accession: GSM662681///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 71///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 1554///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662681/GSM662681.CEL.gz///data_row_count: 54675"
"GSM662682"	NA	"COL2_712"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_712///geo_accession: GSM662682///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1465///characteristics_ch1.6: second apc mutation: 1556///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662682/GSM662682.CEL.gz///data_row_count: 54675"
"GSM662683"	NA	"COL2_713"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"60"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_713///geo_accession: GSM662683///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 60///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER/BONE///characteristics_ch1.5: first apc mutation: 283///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662683/GSM662683.CEL.gz///data_row_count: 54675"
"GSM662684"	NA	"COL2_714"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"48"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_714///geo_accession: GSM662684///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 48///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 213///characteristics_ch1.6: second apc mutation: 1319///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662684/GSM662684.CEL.gz///data_row_count: 54675"
"GSM662685"	NA	"COL2_715"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"69"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_715///geo_accession: GSM662685///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 69///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 1309///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662685/GSM662685.CEL.gz///data_row_count: 54675"
"GSM662686"	NA	"COL2_716"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"68"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-22"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_716///geo_accession: GSM662686///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 68///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1398///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662686/GSM662686.CEL.gz///data_row_count: 54675"
"GSM662687"	NA	"COL2_718"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"83"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_718///geo_accession: GSM662687///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 83///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1345///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662687/GSM662687.CEL.gz///data_row_count: 54675"
"GSM662688"	NA	"COL2_719"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"44"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_719///geo_accession: GSM662688///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 44///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662688/GSM662688.CEL.gz///data_row_count: 54675"
"GSM662689"	NA	"COL2_720"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_720///geo_accession: GSM662689///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1344///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662689/GSM662689.CEL.gz///data_row_count: 54675"
"GSM662690"	NA	"COL2_721"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"68"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_721///geo_accession: GSM662690///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 68///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 232///characteristics_ch1.6: second apc mutation: 1398///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662690/GSM662690.CEL.gz///data_row_count: 54675"
"GSM662691"	NA	"COL2_722"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"64"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_722///geo_accession: GSM662691///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 64///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 232///characteristics_ch1.6: second apc mutation: 1311///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662691/GSM662691.CEL.gz///data_row_count: 54675"
"GSM662692"	NA	"COL2_7225"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"78"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_7225///geo_accession: GSM662692///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 78///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1114///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662692/GSM662692.CEL.gz///data_row_count: 54675"
"GSM662693"	NA	"COL2_723"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"68"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_723///geo_accession: GSM662693///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 68///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 554///characteristics_ch1.6: second apc mutation: 1309///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662693/GSM662693.CEL.gz///data_row_count: 54675"
"GSM662694"	NA	"COL2_724"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_724///geo_accession: GSM662694///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662694/GSM662694.CEL.gz///data_row_count: 54675"
"GSM662695"	NA	"COL2_725"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"80"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-26"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_725///geo_accession: GSM662695///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 80///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 554///characteristics_ch1.6: second apc mutation: 1464///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662695/GSM662695.CEL.gz///data_row_count: 54675"
"GSM662696"	NA	"COL2_726"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"70"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_726///geo_accession: GSM662696///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 70///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662696/GSM662696.CEL.gz///data_row_count: 54675"
"GSM662697"	NA	"COL2_727"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"42"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_727///geo_accession: GSM662697///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 42///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1450///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662697/GSM662697.CEL.gz///data_row_count: 54675"
"GSM662698"	NA	"COL2_729"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"58"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_729///geo_accession: GSM662698///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 58///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: CNS///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662698/GSM662698.CEL.gz///data_row_count: 54675"
"GSM662699"	NA	"COL2_730"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"66"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_730///geo_accession: GSM662699///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 66///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 212///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662699/GSM662699.CEL.gz///data_row_count: 54675"
"GSM662700"	NA	"COL2_731"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"63"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_731///geo_accession: GSM662700///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 63///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 232///characteristics_ch1.6: second apc mutation: 1402///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662700/GSM662700.CEL.gz///data_row_count: 54675"
"GSM662701"	NA	"COL2_732"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"44"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_732///geo_accession: GSM662701///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 44///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662701/GSM662701.CEL.gz///data_row_count: 54675"
"GSM662702"	NA	"COL2_733"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"61"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_733///geo_accession: GSM662702///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 61///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: BONE///characteristics_ch1.5: first apc mutation: 876///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662702/GSM662702.CEL.gz///data_row_count: 54675"
"GSM662703"	NA	"COL2_735"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"42"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_735///geo_accession: GSM662703///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 42///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662703/GSM662703.CEL.gz///data_row_count: 54675"
"GSM662704"	NA	"COL2_737"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"75"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_737///geo_accession: GSM662704///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 75///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 1556///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662704/GSM662704.CEL.gz///data_row_count: 54675"
"GSM662705"	NA	"COL2_738"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"65"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-28"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_738///geo_accession: GSM662705///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 65///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 332///characteristics_ch1.6: second apc mutation: 1450///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662705/GSM662705.CEL.gz///data_row_count: 54675"
"GSM662706"	NA	"COL2_739"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"73"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_739///geo_accession: GSM662706///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 73///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1306///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662706/GSM662706.CEL.gz///data_row_count: 54675"
"GSM662707"	NA	"COL2_741"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"72"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_741///geo_accession: GSM662707///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 72///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1357///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662707/GSM662707.CEL.gz///data_row_count: 54675"
"GSM662708"	NA	"COL2_743"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"56"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_743///geo_accession: GSM662708///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 56///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 232///characteristics_ch1.6: second apc mutation: 1302///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662708/GSM662708.CEL.gz///data_row_count: 54675"
"GSM662709"	NA	"COL2_744"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"68"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_744///geo_accession: GSM662709///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 68///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 499///characteristics_ch1.6: second apc mutation: 1407///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662709/GSM662709.CEL.gz///data_row_count: 54675"
"GSM662710"	NA	"COL2_7610"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"81"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_7610///geo_accession: GSM662710///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 81///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1428///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662710/GSM662710.CEL.gz///data_row_count: 54675"
"GSM662711"	NA	"COL2_79"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"56"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-08-21"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_79///geo_accession: GSM662711///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 56///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662711/GSM662711.CEL.gz///data_row_count: 54675"
"GSM662712"	NA	"COL2_8196"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"84"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_8196///geo_accession: GSM662712///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 84///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 211///characteristics_ch1.6: second apc mutation: 1491///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662712/GSM662712.CEL.gz///data_row_count: 54675"
"GSM662713"	NA	"COL2_8336"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"64"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_8336///geo_accession: GSM662713///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 64///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1322///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662713/GSM662713.CEL.gz///data_row_count: 54675"
"GSM662714"	NA	"COL2_92"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"58"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"r"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_92///geo_accession: GSM662714///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 58///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: LIVER///characteristics_ch1.5: first apc mutation: 1328///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662714/GSM662714.CEL.gz///data_row_count: 54675"
"GSM662715"	NA	"COL2_9243"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"72"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_9243///geo_accession: GSM662715///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 72///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662715/GSM662715.CEL.gz///data_row_count: 54675"
"GSM662716"	NA	"COL2_9304"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"67"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-03"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_9304///geo_accession: GSM662716///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 67///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LUNG///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662716/GSM662716.CEL.gz///data_row_count: 54675"
"GSM662717"	NA	"COL2_95"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"61"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2006-12-12"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_95///geo_accession: GSM662717///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 61///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1345///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 1///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662717/GSM662717.CEL.gz///data_row_count: 54675"
"GSM662718"	NA	"COL2_9607"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"76"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_9607///geo_accession: GSM662718///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 76///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662718/GSM662718.CEL.gz///data_row_count: 54675"
"GSM662719"	NA	"COL2_9736"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"55"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_9736///geo_accession: GSM662719///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 55///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 499///characteristics_ch1.6: second apc mutation: 1309///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662719/GSM662719.CEL.gz///data_row_count: 54675"
"GSM662720"	NA	"COL2_9749"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"67"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"r"	"f"	NA	NA	NA	NA	"n"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_9749///geo_accession: GSM662720///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 67///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Right///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 0///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662720/GSM662720.CEL.gz///data_row_count: 54675"
"GSM662721"	NA	"COL2_9848"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"50"	NA	"norecurrence"	NA	NA	NA	"MSS"	NA	"l"	"m"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-04"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_9848///geo_accession: GSM662721///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 50///characteristics_ch1.2: gender: M///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: 0///characteristics_ch1.5: first apc mutation: 1312///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662721/GSM662721.CEL.gz///data_row_count: 54675"
"GSM662722"	NA	"COL2_JM_HS_1411"	"tumor"	"co"	NA	NA	NA	NA	0	0	"B"	"50"	NA	"recurrence"	NA	NA	NA	"MSS"	NA	"l"	"f"	NA	NA	NA	NA	"y"	NA	NA	"2"	NA	NA	NA	NA	"2008-09-02"	NA	"n"	NA	"n"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	"title: COL2_JM_HS_1411///geo_accession: GSM662722///status: Public on Jan 28 2011///submission_date: Jan 27 2011///last_update_date: Jan 28 2011///type: RNA///channel_count: 1///source_name_ch1: colon adenocarcinoma stage II///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colon adenocarcinoma stage II///characteristics_ch1.1: age at diagnosis: 50///characteristics_ch1.2: gender: F///characteristics_ch1.3: localisation: Left///characteristics_ch1.4: metastasis: LIVER/LUNG///characteristics_ch1.5: first apc mutation: 1291///characteristics_ch1.6: second apc mutation: 0///characteristics_ch1.7: 5q loh: 0///treatment_protocol_ch1: Tissue samples were collected on fresh surgical specimens by pathologists within one hour after surgery from patients who underwent curative colonic resection, then flash frozen in liquid nitrogen and stored at -80C until nucleic acids extraction.///molecule_ch1: total RNA///extract_protocol_ch1: Enriched tumor zones were selected from frozen material on HE-stained cryosections to ensure a 60% minimum of tumor cells. Nucleic acids were extracted using QIAamp and RNeasy kits (Qiagen, Courtaboeuf France) according to the manufacturer's instructions. Quantification of samples was done with a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific, Illkirch France). RNA integrity was controlled on an Agilent Bioanalyzer (Agilent Technologies, Massy France).///label_ch1: biotin///label_protocol_ch1: Biotinylated cRNA were prepared according to the standard Affymetrix protocol///taxid_ch1: 9606///hyb_protocol: Expression profiles were established with Affymetrix U133 Plus 2.0 human oligonucleotide microarrays///scan_protocol: Scanning was done with an Affymetrix GeneArray scanner and quantification with the Affymetrix GeneChip Operating Software (Affymetrix, Paris France).///description: gene expression data from stage II primary colon adenocarcinoma after surgery only///data_processing: CEL files were processed in the R/Bioconductor environment. Pre-processing steps (background adjustment, normalization and summarization) were performed with the GCRMA package///data_processing.1: Expression measures were handled on log2 scale for statistical computations as well as for display purposes. Genes with overall low intensity were removed from further analysis. All remaining genes had an expression value greater than log2 (100) in at least 10% of the samples. As tumor samples and/or RNA samples were provided by 4 different centres, genes were then median-centred within each centre individually.///platform_id: GPL570///contact_name: Sylviane,,Olschwang///contact_email: sylviane.olschwang@inserm.fr///contact_phone: 33(0)491223406///contact_fax: 33(0)491223544///contact_department: Centre de Recherches en Cancrologie de Marseille///contact_institute: Institut Paoli-Calmettes///contact_address: 232 boulevard Sainte-Marguerite///contact_city: Marseille///contact_zip.postal_code: 13009///contact_country: France///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM662nnn/GSM662722/GSM662722.CEL.gz///data_row_count: 54675"
